Back to Search
Start Over
Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease.
- Source :
- Cardiac Electrophysiology Clinics; 2023 Supplement, Vol. 15 Issue 4, pe1-e16, 16p
- Publication Year :
- 2023
-
Abstract
- Subcutaneous implantable cardioverter defibrillators (S-ICDs) are being used with increased frequency in children and patients with congenital heart disease. Vascular access complexities, intracardiac shunts, and specific anatomies make these devices particularly appealing for some of these patients. Alternative screening, implantation, and programming techniques should be considered based on patient size, body habitus, anatomy, procedural history, and preference. Appropriate and inappropriate shock rates are generally comparable to those seen with transvenous devices. Complications such as infection can occur, although their severity is likely to be less than that seen with transvenous devices. Technical advances are likely to further broaden S-ICD applicability. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 18779182
- Volume :
- 15
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- Cardiac Electrophysiology Clinics
- Publication Type :
- Academic Journal
- Accession number :
- 173853821
- Full Text :
- https://doi.org/10.1016/j.ccep.2023.09.002